Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy

被引:164
|
作者
Weiss, SM
Roblin, PM
Gaydos, CA
Cummings, P
Patton, DL
Schulhoff, N
Shani, J
Frankel, R
Penney, K
Quinn, TC
Hammerschlag, MR
Schachter, J
机构
[1] SUNY HLTH SCI CTR,DEPT MED,DIV INFECT DIS,BROOKLYN,NY 11203
[2] SUNY HLTH SCI CTR,DEPT PEDIAT,DIV INFECT DIS,BROOKLYN,NY 11203
[3] MAIMONIDES HOSP,DIV CARDIOL,BROOKLYN,NY 11219
[4] JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV INFECT DIS,BALTIMORE,MD
[5] NIAID,IMMUNOREGULAT LAB,BETHESDA,MD 20892
[6] WASHINGTON UNIV,DEPT OBSTET & GYNECOL,SEATTLE,WA
[7] UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143
来源
JOURNAL OF INFECTIOUS DISEASES | 1996年 / 173卷 / 04期
关键词
D O I
10.1093/infdis/173.4.957
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To further investigate a proposed relationship between Chlamydia pneumoniae and coronary heart disease, coronary atheromas were collected from patients undergoing percutaneous atherectomy, Fifty-eight atheroma specimens were examined by culture and polymerase chain reaction (PCR) and 22 by electron microscopy, All were negative for C. pneumoniae, except a single specimen that was PCR-positive, These results differ from studies in other populations, in which this organism was identified by nonculture methods within coronary atheromas obtained at autopsy, Anti-C, pneumoniae antibody titers from 65 of the patients were compared with those of 28 asymptomatic controls, IgG titers were higher in controls than in patients, There is no evidence that C. pneumoniae exists within atheromas in this study population, nor does seroprevalence correlate with the presence of coronary disease in these patients.
引用
收藏
页码:957 / 962
页数:6
相关论文
共 50 条
  • [31] Chlamydia pneumoniae Infection and Restenosis in Patients with Coronary Heart Disease
    R. Krausse
    J. Leiendecker
    G. Herrmann
    T. Harder
    U. Ullmann
    Infection, 2003, 31 : 149 - 154
  • [32] Prevalence of Chlamydia pneumoniae infection in patients with coronary artery disease
    Wang, S
    Tondella, MLC
    Rao, S
    Liu, G
    Austin, H
    Fields, B
    Zafari, AMM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E51 - E51
  • [33] Chlamydia pneumoniae and future risk in patients with coronary heart disease
    Haim, M
    Tanne, D
    Battler, A
    Boyko, V
    Reshef, T
    Goldbourt, U
    Brunner, D
    Mekori, YA
    Behar, S
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 93 (01) : 25 - 30
  • [34] Chlamydia pneumoniae infection and restenosis in patients with coronary heart disease
    Krausse, R
    Leiendecker, J
    Herrmann, G
    Harder, T
    Ullmann, U
    INFECTION, 2003, 31 (03) : 149 - 154
  • [35] Serology, PCR and IHC for the detection of Chlamydia pneumoniae in patients undergoing bronchoscopy
    Koyi, H
    Brandén, E
    Gnarpe, J
    Gnarpe, H
    Steen, B
    BRONCHOLOGY AND BRONCHOESOPHAGOLOGY: STATE OF THE ART, 2001, 1217 : 587 - 589
  • [36] Detection of DNA Chlamydia pneumoniae in coronary atherectomy tissues is predicted by its presence in circulating leukocytes, but not by serologic markers
    Przyluski, J
    Kruk, M
    Podsiadly, E
    Chmielak, Z
    Demkow, M
    Pregowski, J
    Tylewska-Wierzbanowska, S
    Ruzyllo, W
    EUROPEAN HEART JOURNAL, 2003, 24 : 428 - 428
  • [37] Detection of Chlamydophila pneumoniae (Chlamydia pneumoniae) in endarteroctomy specimens of coronary heart diseases patients
    Satpathy, Gita
    Bhan, Anil
    Sharma, Anjana
    Kar, U. K.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2008, 128 (05) : 658 - 662
  • [38] Chlamydia pneumoniae in coronary artery disease
    Garfinkel, E
    Bozovich, G
    Mautner, B
    CIRCULATION, 2000, 101 (10) : E95 - E95
  • [39] Chlamydia pneumoniae and coronary heart disease
    Carlisle, SS
    Nahata, MC
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (05) : 615 - 622
  • [40] Chlamydia pneumoniae and acute coronary syndrome
    Mitchell, WM
    Stratton, CW
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (05): : 525 - 526